Taking into account that CD44 and CD133 have substantial expression in untreated cells that cannot all be CSCs, their elevation in RTP state is supposed not so much the feature of cancer stemness than a critical factor supporting survival of RTP cells. This evidence concerns the gene CD44 and cancer.